CoreCap Advisors’s CVS Health CVS Stock Holding History

CoreCap Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$360K	Buy	3,481 +139	+4%	+$12.4K	0.01%	655
2026 Q1	$240K	Sell	3,342 -41	-1%	-$3.16K	0.01%	743
2025 Q4	$268K	Sell	3,383 -357	-10%	-$28.1K	0.01%	691
2025 Q3	$282K	Sell	3,740 -268	-7%	-$18.4K	0.01%	693
2025 Q2	$276K	Sell	4,008 -365	-8%	-$23.9K	0.01%	655
2025 Q1	$296K	Buy	4,373 +45	+1%	+$2.69K	0.01%	592
2024 Q4	$194K	Buy	4,328 +679	+19%	+$38.1K	0.01%	716
2024 Q3	$229K	Buy	+3,649	New	+$213K	0.01%	636
2024 Q2	–	Sell	-3,607	Closed	-$288K	–	1824
2024 Q1	$288K	Buy	3,607 +550	+18%	+$42K	0.02%	538
2023 Q4	$241K	Buy	3,057 +186	+6%	+$13.2K	0.02%	515
2023 Q3	$200K	Buy	+2,871	New	+$203K	0.01%	507
2022 Q4	$515K	Buy	5,523 +929	+20%	+$89.6K	0.04%	347
2022 Q3	$438K	Buy	4,594 +1,705	+59%	+$169K	0.04%	338
2022 Q2	$268K	Sell	2,889 -805	-22%	-$78.6K	0.02%	447
2022 Q1	$374K	Sell	3,694 -323	-8%	-$33.9K	0.03%	368
2021 Q4	$414K	Buy	+4,017	New	+$371K	0.03%	390

Other funds holding CVS

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

CoreCap Advisors's CVS Position: Q2 2026 in Review

CoreCap Advisors increased its CVS Health (CVS) stake by 4.2% in Q2 2026, buying an estimated $12.4K and bringing the position to 3,481 shares worth $360K. The position accounts for 0.01% of the portfolio, ranked #655.

CoreCap Advisors first reported a position in CVS in Q4 2021 and has held it in 16 quarters since. The position peaked at $515K in Q4 2022. 578 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

CoreCap Advisors held 3,481 shares of CVS Health worth $360K as of Q2 2026.
CoreCap Advisors bought 139 CVS Health shares in Q2 2026, an estimated $12.4K.
CVS Health made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #655 holding.
CoreCap Advisors first reported a position in CVS Health in Q4 2021 and has held it in 16 quarters since.
CoreCap Advisors's CVS Health position peaked at $515K in Q4 2022.
578 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.